• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从诱导多能干细胞高效诱导多巴胺能神经元分化揭示了PARK2神经元中的线粒体自噬受损。

Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.

作者信息

Suzuki Sadafumi, Akamatsu Wado, Kisa Fumihiko, Sone Takefumi, Ishikawa Kei-Ichi, Kuzumaki Naoko, Katayama Hiroyuki, Miyawaki Atsushi, Hattori Nobutaka, Okano Hideyuki

机构信息

Department of Physiology, Keio University, School of Medicine, Tokyo, Japan.

Center for Genomic and Regenerative Medicine, Juntendo University, School of Medicine, Tokyo, Japan.

出版信息

Biochem Biophys Res Commun. 2017 Jan 29;483(1):88-93. doi: 10.1016/j.bbrc.2016.12.188. Epub 2017 Jan 3.

DOI:10.1016/j.bbrc.2016.12.188
PMID:28057485
Abstract

Patient-specific induced pluripotent stem cells (iPSCs) show promise for use as tools for in vitro modeling of Parkinson's disease. We sought to improve the efficiency of dopaminergic (DA) neuron induction from iPSCs by the using surface markers expressed in DA progenitors to increase the significance of the phenotypic analysis. By sorting for a CD184/CD44 fraction during neural differentiation, we obtained a population of cells that were enriched in DA neuron precursor cells and achieved higher differentiation efficiencies than those obtained through the same protocol without sorting. This high efficiency method of DA neuronal induction enabled reliable detection of reactive oxygen species (ROS) accumulation and vulnerable phenotypes in PARK2 iPSCs-derived DA neurons. We additionally established a quantitative system using the mt-mKeima reporter system to monitor mitophagy in which mitochondria fuse with lysosomes and, by combining this system with the method of DA neuronal induction described above, determined that mitophagy is impaired in PARK2 neurons. These findings suggest that the efficiency of DA neuron induction is important for the precise detection of cellular phenotypes in modeling Parkinson's disease.

摘要

患者特异性诱导多能干细胞(iPSC)有望用作帕金森病体外建模的工具。我们试图通过使用多巴胺能(DA)祖细胞中表达的表面标志物来提高从iPSC诱导DA神经元的效率,以增强表型分析的意义。在神经分化过程中通过分选CD184/CD44组分,我们获得了富含DA神经元前体细胞的细胞群体,并且与未分选的相同方案相比,实现了更高的分化效率。这种高效的DA神经元诱导方法能够可靠地检测PARK2 iPSC衍生的DA神经元中的活性氧(ROS)积累和易损表型。我们还使用线粒体靶向的红色荧光蛋白(mt-mKeima)报告系统建立了一个定量系统来监测线粒体自噬,即线粒体与溶酶体融合,并通过将该系统与上述DA神经元诱导方法相结合,确定PARK2神经元中的线粒体自噬受损。这些发现表明,DA神经元诱导效率对于在帕金森病建模中精确检测细胞表型很重要。

相似文献

1
Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.从诱导多能干细胞高效诱导多巴胺能神经元分化揭示了PARK2神经元中的线粒体自噬受损。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):88-93. doi: 10.1016/j.bbrc.2016.12.188. Epub 2017 Jan 3.
2
Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.携带SNCA、LRRK2、PARK2和GBA突变的帕金森病患者无整合诱导多能干细胞系的衍生、表征及神经分化
PLoS One. 2016 May 18;11(5):e0154890. doi: 10.1371/journal.pone.0154890. eCollection 2016.
3
Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons.诱导多能干细胞来源的神经干细胞向多巴胺能神经元的分化
Methods Mol Biol. 2019;1919:89-96. doi: 10.1007/978-1-4939-9007-8_7.
4
Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.帕金森病基因 PARKIN 导致多巴胺能神经元中线粒体改变:使用 PARK2 患者特异性和 PARK2 基因敲除同基因诱导多能干细胞系。
Stem Cell Reports. 2015 May 12;4(5):847-59. doi: 10.1016/j.stemcr.2015.02.019. Epub 2015 Apr 2.
5
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.基于人胚胎干细胞(hESC)、人诱导多能干细胞(hiPSC)和非人类灵长类动物 iPSC 来源的多巴胺能神经元的分化效率和安全性改进的帕金森病细胞治疗方案。
Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.
6
Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.多能干细胞衍生的多巴胺能亚群模拟帕金森病中的选择性神经元变性。
Stem Cell Reports. 2021 Nov 9;16(11):2718-2735. doi: 10.1016/j.stemcr.2021.09.014. Epub 2021 Oct 21.
7
Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.合成 mRNA 可高效诱导 iPS 细胞分化为多巴胺能神经元。
Stem Cells Transl Med. 2019 Feb;8(2):112-123. doi: 10.1002/sctm.18-0036. Epub 2018 Nov 1.
8
Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.从帕金森病患者中生成嗜幼稚型诱导多能干细胞用于高效基因操作和疾病建模。
Stem Cells Dev. 2015 Nov 1;24(21):2591-604. doi: 10.1089/scd.2015.0079. Epub 2015 Sep 1.
9
Assay for Assessing Mitochondrial Function in iPSC-Derived Neural Stem Cells and Dopaminergic Neurons.用于评估诱导多能干细胞衍生的神经干细胞和多巴胺能神经元中线粒体功能的检测方法。
Methods Mol Biol. 2019;1919:161-173. doi: 10.1007/978-1-4939-9007-8_12.
10
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.黑质多巴胺能神经元上生长激素释放肽受体的下调导致类似帕金森病的运动功能障碍。
Mol Brain. 2018 Feb 20;11(1):6. doi: 10.1186/s13041-018-0349-8.

引用本文的文献

1
Targeting mitophagy in neurodegenerative diseases.针对神经退行性疾病中的线粒体自噬
Nat Rev Drug Discov. 2025 Apr;24(4):276-299. doi: 10.1038/s41573-024-01105-0. Epub 2025 Jan 14.
2
Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease.用于帕金森病的诱导多能干细胞相关方法来生成多巴胺能神经元。
Neural Regen Res. 2025 Nov 1;20(11):3193-3206. doi: 10.4103/NRR.NRR-D-24-00771. Epub 2024 Dec 7.
3
Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson's Disease Pathogenesis.
与突触小泡蛋白改变相关的多巴胺稳态失调:帕金森病发病机制的一个潜在中枢机制。
Aging Dis. 2024 May 7;15(3):1204-1226. doi: 10.14336/AD.2023.0821-2.
4
Reduced ER-mitochondrial contact sites and mitochondrial Ca flux in -mutant patient tyrosine hydroxylase reporter iPSC lines.突变患者酪氨酸羟化酶报告诱导多能干细胞系中内质网-线粒体接触位点减少及线粒体钙通量降低。
Front Cell Dev Biol. 2023 Sep 8;11:1171440. doi: 10.3389/fcell.2023.1171440. eCollection 2023.
5
A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson's disease.一种将人类诱导多能干细胞分化为中脑多巴胺能祖细胞的明确方法,该方法可安全恢复帕金森病患者的运动功能障碍。
Front Neurosci. 2023 Jul 12;17:1202027. doi: 10.3389/fnins.2023.1202027. eCollection 2023.
6
Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.临床无症状杂合PRKN变异携带者线粒体功能障碍的分子表型
NPJ Parkinsons Dis. 2023 Apr 18;9(1):65. doi: 10.1038/s41531-023-00499-9.
7
ZLN005 improves the survival of polymicrobial sepsis by increasing the bacterial killing inducing lysosomal acidification and biogenesis in phagocytes.ZLN005 通过增加吞噬细胞中的溶酶体酸化和生物发生来提高多微生物脓毒症的存活率,从而增强杀菌作用。
Front Immunol. 2023 Feb 3;14:1089905. doi: 10.3389/fimmu.2023.1089905. eCollection 2023.
8
Mitophagy and reactive oxygen species interplay in Parkinson's disease.线粒体自噬与活性氧在帕金森病中的相互作用。
NPJ Parkinsons Dis. 2022 Oct 18;8(1):135. doi: 10.1038/s41531-022-00402-y.
9
Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.阿尔茨海默病相关tau 修饰物选择性破坏 Drp1 非依赖性自噬体和线粒体溶酶体运输在新型秀丽隐杆线虫模型中的作用。
Genetics. 2022 Aug 30;222(1). doi: 10.1093/genetics/iyac104.
10
Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson's Disease.帕金森病中自噬的标志和分子工具研究。
Cells. 2022 Jul 2;11(13):2097. doi: 10.3390/cells11132097.